Tandem Diabetes Care (TNDM) Cash & Equivalents Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) Cash & Equivalents Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 32.23% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -21.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.68% |
| Mar 31, 2026 | 11.96% |
| Dec 31, 2025 | -19.31% |
| Sep 30, 2025 | -9.44% |
| Jun 30, 2025 | -17.69% |
| Mar 31, 2025 | -17.00% |
| Dec 31, 2024 | -0.92% |
| Sep 30, 2024 | -24.15% |
| Jun 30, 2024 | -21.49% |
| Mar 31, 2024 | -21.26% |
| Dec 31, 2023 | -14.63% |
| Sep 30, 2023 | -14.97% |
| Jun 30, 2023 | -16.24% |
| Mar 31, 2023 | 19.70% |
| Dec 31, 2022 | 49.94% |
| Sep 30, 2022 | 39.03% |
| Jun 30, 2022 | 44.43% |
| Mar 31, 2022 | 32.31% |
| Dec 31, 2021 | 19.39% |
| Sep 30, 2021 | -0.36% |